Acupoint stimulation for long COVID: A promising intervention: 穴位刺激治疗长新冠: 一种有前景的干预措施
BW Feng, PJ Rong - World Journal of Acupuncture-Moxibustion, 2023 - Elsevier
… Several antiviral drugs, such as remdesivir, molnupiravir, and irmatrelvir, remain … 139
patients with COVID-19 with moderate-to-severe symptoms and investigated the clinical outcomes …
patients with COVID-19 with moderate-to-severe symptoms and investigated the clinical outcomes …
[HTML][HTML] 重症类型的新型冠状病毒肺炎: 发病机制, 预警指标和治疗
SHI Ke, LIU Yao, Q ZHANG, C RAN, HOU Jie… - 中国结合医学杂志(英文版) - en.cjim.cn
… of critical illness in hospitalized patients with COVID-19. JAMA Intern … treatment with Qingfei
Paidu Decoction and favorable clinical outcomes in patients with COVID-19: a retrospective …
Paidu Decoction and favorable clinical outcomes in patients with COVID-19: a retrospective …
[HTML][HTML] Acupoint stimulation for long COVID: A promising intervention: 穴位刺激治疗长新冠: 一种有前景的干预措施
BW Feng, PJ Rong - World Journal of Acupuncture-Moxibustion - ncbi.nlm.nih.gov
… Several antiviral drugs, such as remdesivir, molnupiravir, and irmatrelvir, remain … 139
patients with COVID-19 with moderate-to-severe symptoms and investigated the clinical outcomes …
patients with COVID-19 with moderate-to-severe symptoms and investigated the clinical outcomes …
妊娠期新型冠状病毒肺炎研究进展
梁毓， 王树玉 - 中华实验和临床感染病杂志(电子版), 2021 - zhsyhlcgrbzz.cma-cmc.com.cn
… in pregnant patients are fever, cough, dyspnea and lymphopenia. Most patients have good …
that pregnant women had poor clinical outcomes due to COVID-19 disease. Up to September …
that pregnant women had poor clinical outcomes due to COVID-19 disease. Up to September …
奎寧類藥物用於冠狀病毒病(COVID-19) 治療之效益風險考量
陳立奇 - 臺灣臨床藥學雜誌, 2020 - airitilibrary.com
… 治療有幫助之藥物如奎寧類藥物, 抗病毒藥物如remdesivir,lopinavir/ritonavir, … Retrospective
multicenter cohort study … of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J …
multicenter cohort study … of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J …
[HTML][HTML] 侧卧位通气治疗新型冠状病毒肺炎重症患者的临床研究
周岐龙， 潘鹏飞， 卢花， 岳希， 赵建新… - 中华重症医学 …, 2021 - icu.cma-cmc.com.cn
… clinical effects of lateral position ventilation in the patients … Retrospectively collecting data of
41 COVID-19 patients with … distress syndrome (ARDS) hospitalized in the critical emergency …
41 COVID-19 patients with … distress syndrome (ARDS) hospitalized in the critical emergency …
[PDF][PDF] 新型冠状病毒肺炎下肾脏损伤相关的Meta 分析
李天宇， 甘文渊， 陈文莉 - 中华肾脏病杂志, 2021 - cjn.org.cn
… Compassionate remdesivir treatment of severe Covid⁃19 … patients: clinical outcome and
differences in post ⁃ treatment … with COVID⁃19 in Wuhan, China: a retrospective cohort study[J]. …
differences in post ⁃ treatment … with COVID⁃19 in Wuhan, China: a retrospective cohort study[J]. …
2020 年《 系统性硬化症和COVID-19 大流行: 世界硬皮病基金会对患者管理的初步建议》 解读
崔洁涵， 杨林， 汪晓平， 何晶晶， 彭晓欣， 冯星， 马隽… - 中国全科医学, 2021 - chinagp.net
… Remdesivir in adults with severe COVID-19:a randomised,… ritonavir in adults hospitalized
with severe covid-19[J]. N … inpatients with COVID-19 in Wuhan,China: a retrospective cohort …
with severe covid-19[J]. N … inpatients with COVID-19 in Wuhan,China: a retrospective cohort …
[PDF][PDF] 新型冠状病毒肺炎的抗病毒治疗进展
石浩川， 潘蕾 - 中国现代医药杂志, 2024 - zgxdyyzz.com.cn
… A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe
COVID-19[… Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19(…
COVID-19[… Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19(…
[HTML][HTML] COVID-19 治疗药物的研究进展
杨璐， 王辉强， 李玉环 - 药学学报, 2020 - html.rhhz.net
… 直接靶向病毒和靶向宿主是抗病毒药物研发的两个策略, 目前针对COVID-19 治疗药物的研发,
在这两个… 同时结合中药在治疗新冠肺炎中发挥的作用, 探讨和展望COVID-19 药物治疗的策略. …
在这两个… 同时结合中药在治疗新冠肺炎中发挥的作用, 探讨和展望COVID-19 药物治疗的策略. …